Document is current
Any future updates will be listed below
-
Authors
Patel, Jaymin M. https://orcid.org/0000-0001-9945-5555
Goss, Andrew
Garber, Judy E.
Torous, Vanda
Richardson, Edward T.
Haviland, Miriam J.
Hacker, Michele R.
Freeman, Gordon J. https://orcid.org/0000-0002-7210-5616
Nalven, Tessa
Alexander, Brian
Lee, Larissa
Collins, Laura C.
Schnitt, Stuart J.
Tung, Nadine
- License Information
-
More Information
Article History
Received: 19 August 2019
Accepted: 30 April 2020
First Online: 5 June 2020
Competing interests
: L.L. has institutional funding for investigator-initiated trial and sponsored travel from AstraZeneca. G.J.F. has patents/pending royalties on the PD-1/PD-L1 pathway from Roche, Merck MSD, Bristol-Myers Squibb, Merck KGA, Boehringer Ingelheim, AstraZeneca, Dako, Leica, Mayo Clinic, and Novartis. G.J.F. has served on advisory boards for Roche, Bristol-Myers Squibb, Xios, Origimed, Triursus, iTeos, and NextPoint. J.M.P., A.G., J.E.G., V.T., E.T.R., M.J.H., M.R.H., T.N., B.A., L.C.C., S.J.S., and N.T. declare no competing interests.
